Acuren Corp (NYSEAMERICAN:TIC) Receives Consensus Rating of “Hold” from Analysts

Shares of Acuren Corp (NYSEAMERICAN:TICGet Free Report) have received an average recommendation of “Hold” from the six ratings firms that are currently covering the stock, Marketbeat reports. Four analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $14.3750.

A number of analysts recently weighed in on the stock. JPMorgan Chase & Co. assumed coverage on shares of Acuren in a research report on Friday. They issued an “overweight” rating and a $16.00 price objective on the stock. Zacks Research raised Acuren to a “hold” rating in a research note on Tuesday, December 16th. UBS Group reduced their price target on Acuren from $15.00 to $11.50 and set a “neutral” rating on the stock in a report on Friday, November 14th. Jefferies Financial Group restated a “buy” rating and set a $15.00 price objective on shares of Acuren in a report on Friday, November 14th. Finally, Baird R W upgraded shares of Acuren to a “hold” rating in a report on Thursday, October 9th.

Check Out Our Latest Stock Analysis on Acuren

Institutional Trading of Acuren

A number of large investors have recently modified their holdings of the company. HB Wealth Management LLC bought a new stake in Acuren during the second quarter valued at about $166,000. Goldman Sachs Group Inc. bought a new position in Acuren in the first quarter worth about $4,429,000. Geode Capital Management LLC purchased a new stake in shares of Acuren during the second quarter valued at about $25,003,000. Ameritas Investment Partners Inc. bought a new stake in shares of Acuren in the 2nd quarter valued at about $117,000. Finally, ProShare Advisors LLC purchased a new position in shares of Acuren in the 2nd quarter worth approximately $234,000.

Acuren Trading Up 8.9%

TIC stock opened at $10.88 on Friday. Acuren has a twelve month low of $8.76 and a twelve month high of $14.94. The firm’s fifty day simple moving average is $10.24 and its two-hundred day simple moving average is $11.18.

About Acuren

(Get Free Report)

Acuren Group Inc (NYSEAMERICAN:TIC) is a leading provider of non‐destructive testing (NDT), inspection, engineering and consulting services to the energy, petrochemical, manufacturing and infrastructure sectors. The company employs a range of advanced testing techniques—such as ultrasonic, radiographic, magnetic particle, liquid penetrant, eddy current and acoustic emission—to evaluate the integrity of pressure vessels, pipelines, storage tanks and other critical assets. By combining field inspections with laboratory analysis, Acuren helps clients identify defects, prevent equipment failures and meet regulatory requirements.

In addition to core NDT capabilities, Acuren offers specialty engineering and consulting services including fitness‐for‐service assessments, corrosion under insulation surveys, mechanical integrity programs, failure analysis and field machining.

Read More

Analyst Recommendations for Acuren (NYSEAMERICAN:TIC)

Receive News & Ratings for Acuren Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acuren and related companies with MarketBeat.com's FREE daily email newsletter.